BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31319393)

  • 1. Patterns of Surveillance Advanced Imaging and Serum Tumor Biomarker Testing Following Launch of the Choosing Wisely Initiative.
    Miles RC; Lee CI; Sun Q; Bansal A; Lyman GH; Specht JM; Fedorenko CR; Greenwood-Hickman MA; Ramsey SD; Lee JM
    J Natl Compr Canc Netw; 2019 Jul; 17(7):813-820. PubMed ID: 31319393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of posttreatment imaging and biomarkers in survivors of early-stage breast cancer: Inappropriate surveillance or necessary care?
    Hahn EE; Tang T; Lee JS; Munoz-Plaza CE; Shen E; Rowley B; Maeda JL; Mosen DM; Ruckdeschel JC; Gould MK
    Cancer; 2016 Mar; 122(6):908-16. PubMed ID: 26650715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline Estimates of Adherence to American Society of Clinical Oncology/American Board of Internal Medicine Choosing Wisely Initiative Among Patients With Cancer Enrolled With a Large Regional Commercial Health Insurer.
    Ramsey SD; Fedorenko C; Chauhan R; McGee R; Lyman GH; Kreizenbeck K; Bansal A
    J Oncol Pract; 2015 Jul; 11(4):338-43. PubMed ID: 26060225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with imaging in patients with early breast cancer after initial treatment.
    Enright K; Desai T; Sutradhar R; Gonzalez A; Powis M; Taback N; Booth CM; Trudeau ME; Krzyzanowska MK
    Curr Oncol; 2018 Apr; 25(2):126-132. PubMed ID: 29719428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A National Study of the Use of Asymptomatic Systemic Imaging for Surveillance Following Breast Cancer Treatment (AFT-01).
    Schumacher JR; Neuman HB; Chang GJ; Kozower BD; Edge SB; Yu M; Vanness DJ; Si Y; Jacobs EA; Francescatti AB; Spears PA; Havlena J; Adesoye T; McKellar D; Winchester D; Burnside ES; Greenberg CC;
    Ann Surg Oncol; 2018 Sep; 25(9):2587-2595. PubMed ID: 29777402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Impact of ASCO Choosing Wisely Guidelines on Staging Imaging for Early-Stage Breast Cancers: A Time Series Analysis Using SEER-Medicare Data.
    Baltz AP; Siegel ER; Kamal AH; Siegel R; Kozlik MM; Crist STS; Makhoul I;
    JCO Oncol Pract; 2023 Feb; 19(2):e274-e285. PubMed ID: 36375114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor marker usage and medical care costs among older early-stage breast cancer survivors.
    Ramsey SD; Henry NL; Gralow JR; Mirick DK; Barlow W; Etzioni R; Mummy D; Thariani R; Veenstra DL
    J Clin Oncol; 2015 Jan; 33(2):149-55. PubMed ID: 25332254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of imaging and biomarker tests for posttreatment care of early-stage breast cancer survivors.
    Hahn EE; Hays RD; Kahn KL; Litwin MS; Ganz PA
    Cancer; 2013 Dec; 119(24):4316-24. PubMed ID: 24105101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in the use of advanced imaging at the time of breast cancer diagnosis in a statewide registry.
    Henry NL; Braun TM; Breslin TM; Gorski DH; Silver SM; Griggs JJ
    Cancer; 2017 Aug; 123(15):2975-2983. PubMed ID: 28301680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced imaging modalities in early stage breast cancer: preoperative use in the United States Medicare population.
    Crivello ML; Ruth K; Sigurdson ER; Egleston BL; Evers K; Wong YN; Boraas M; Bleicher RJ
    Ann Surg Oncol; 2013 Jan; 20(1):102-10. PubMed ID: 22878617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced diagnostic breast cancer imaging: variation and patterns of care in Washington state.
    Gold LS; Buist DS; Loggers ET; Etzioni R; Kessler L; Ramsey SD; Sullivan SD
    J Oncol Pract; 2013 Sep; 9(5):e194-202. PubMed ID: 23943885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance testing among survivors of early-stage breast cancer.
    Keating NL; Landrum MB; Guadagnoli E; Winer EP; Ayanian JZ
    J Clin Oncol; 2007 Mar; 25(9):1074-81. PubMed ID: 17369571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of imaging for staging of early-stage breast cancer in two integrated health care systems: adherence with a choosing wisely recommendation.
    Hahn EE; Tang T; Lee JS; Munoz-Plaza C; Adesina JO; Shen E; Rowley B; Maeda JL; Mosen DM; Ruckdeschel JC; Gould MK
    J Oncol Pract; 2015 May; 11(3):e320-8. PubMed ID: 25901056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unwarranted imaging for distant metastases in patients with newly diagnosed ductal carcinoma in situ and stage I and II breast cancer.
    Lupichuk S; Tilley D; Surgeoner B; King K; Joy AA
    Can J Surg; 2020 Feb; 63(2):E100-E109. PubMed ID: 32109016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of choosing wisely on imaging in men with newly diagnosed prostate cancer.
    Lange SM; Choudry MM; Hunt TC; Ambrose JP; Haaland BA; Lowrance WT; Hanson HA; O'Neil BB
    Urol Oncol; 2023 Jan; 41(1):48.e19-48.e26. PubMed ID: 36307366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance and monitoring in breast cancer survivors: maximizing benefit and minimizing harm.
    Jochelson M; Hayes DF; Ganz PA
    Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer recurrence diagnosis suspected on tumor marker rising: value of whole-body 18FDG-PET/CT imaging and impact on patient management.
    Champion L; Brain E; Giraudet AL; Le Stanc E; Wartski M; Edeline V; Madar O; Bellet D; Pecking A; Alberini JL
    Cancer; 2011 Apr; 117(8):1621-9. PubMed ID: 21472709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multiparametric [
    Leithner D; Horvat JV; Bernard-Davila B; Helbich TH; Ochoa-Albiztegui RE; Martinez DF; Zhang M; Thakur SB; Wengert GJ; Staudenherz A; Jochelson MS; Morris EA; Baltzer PAT; Clauser P; Kapetas P; Pinker K
    Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1878-1888. PubMed ID: 31197455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive Imaging Surveillance of Survivors of Breast Cancer May Increase Risk of Radiation-induced Malignancy.
    Meyer C; Millán P; González V; Spera G; Machado A; Mackey JR; Fresco R
    Clin Breast Cancer; 2019 Jun; 19(3):e468-e474. PubMed ID: 30850181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal trends and regional variation in the utilization of low-value breast cancer care: has the Choosing Wisely campaign made a difference?
    Neuner JM; Nattinger AB; Yen T; McGinley E; Nattinger M; Pezzin LE
    Breast Cancer Res Treat; 2019 Jul; 176(1):205-215. PubMed ID: 30972612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.